Simble Solutions is on the cusp of revealing initial results from its NanoSensor technology development, targeting major markets including Industrial IoT, defence sensing, and wearable medical devices.
- NanoSensor platform development nearing first commercial results
- Applications span gas detection, UV sensing, e-skin, and defence
- Targets multi-billion dollar Industrial IoT, CBRNe, and medical markets
- Five-stage framework guides evaluation and commercialisation pathway
- Potential for Simble-branded sensor devices with vertical integration
NanoSensor Development Approaches Commercial Milestones
Simble Solutions Ltd (ASX:SIS) is advancing rapidly towards initial outcomes from its structured development program for its exclusively licensed NanoSensor technology. The company’s program, building on years of foundational research and prototype development acquired through its December 2025 Next Nano acquisition, is now producing substantial laboratory data and working devices. These early results, expected imminently, will shed light on which application areas hold the strongest commercial promise.
Simble’s CEO Fadi Geha emphasised the company’s commitment to a rigorous, transparent process: “We are not pre-committing to any specific outcome. We are committing to a structured, transparent process and to reporting our findings as they emerge.” This approach aims to clarify the commercial trajectory of the NanoSensor platform for shareholders as it unfolds.
Diverse Applications Target High-Value Markets
The NanoSensor platform is being evaluated across a spectrum of applications including gas detection, ultraviolet and wavelength sensing, e-skin and flexible electronics, multi-sensor integration, and defence and security uses. Each area represents a distinct commercial opportunity, with the development program designed to validate and prioritise pathways that offer the most compelling commercial cases.
These applications align with some of the largest and fastest-growing markets globally. The Industrial Internet of Things (IoT) market alone is projected to reach US$1.69 trillion by 2030, while CBRNe defence sensing is forecast at US$30 billion by 2033, and wearable medical devices at US$139 billion by 2035. Conventional sensor technologies face structural limitations in size, sensitivity, and power consumption within these segments, positioning Simble’s nanosensor platform as a potential disruptor.
Structured Five-Stage Development Framework
Simble has implemented a clear five-stage framework guiding each application from initial sensor fabrication through to potential customer trials. This methodical approach provides a consistent basis for evaluating commercial viability and reporting progress to shareholders. It also supports strategic decision-making on where to accelerate development efforts.
In parallel, Simble’s engineering teams are working on integrating the NanoSensor outputs with its SimbleSense and CarbonView platforms, aiming to shorten the timeline between commercialisation decisions and customer-ready solutions. This integration strategy could enhance the value proposition of any successful sensor application.
Pathway to Vertical Integration and Market Impact
Successful commercialisation of any NanoSensor application could pave the way for Simble-branded sensor devices. Vertical integration would improve product economics and enable deeper technical synergies across the platform, potentially strengthening Simble’s position in energy, environmental data, ESG reporting, and Industrial IoT markets.
The company’s exclusive global commercialisation licence, held through its subsidiary Next Nano, gives it control over a technology platform that combines molecular-level sensitivity, ultra-low power consumption, and a sub-millimetre form factor, features rarely found together in existing sensor hardware.
As the world increasingly relies on embedded sensors in infrastructure, wearables, medical devices, and industrial systems, Simble’s NanoSensor technology could address critical gaps where conventional sensors fall short. The upcoming initial outcomes will be closely watched for indications of which commercial pathways Simble will pursue aggressively.
Bottom Line?
Simble’s disciplined evaluation of its NanoSensor platform is nearing a pivotal moment, with initial results set to clarify which high-value markets it can realistically target next.
Questions in the middle?
- Which specific application areas will emerge as commercially viable from the initial outcomes?
- How quickly can Simble transition from prototype to customer trials and revenue generation?
- What partnerships or pilot programs might Simble pursue to accelerate market adoption?